Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New antiarrhythmic drugs. II. Flecainide.

Literature DB >> 2118629

New antiarrhythmic drugs. II. Flecainide.

A Schneeweiss¹.

Abstract

Entities: Chemical

Mesh：

Substances：
Flecainide

Year: 1990 PMID： 2118629 DOI： 10.1007/BF02238844

Source DB: PubMed Journal: Pediatr Cardiol ISSN： 0172-0643 Impact factor: 1.655

× No keyword cloud information.

13 in total

1. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.

Authors: H J Duff; D M Roden; R J Maffucci; B S Vesper; G J Conard; S B Higgins; J A Oates; R F Smith; R L Woosley
Journal: Am J Cardiol Date: 1981-12 Impact factor: 2.778

2. Electrophysiological effects of a new antiarrhythmic agent, flecainide, on the intact canine heart.

Authors: A B Hodess; W P Follansbee; J F Spear; E N Moore
Journal: J Cardiovasc Pharmacol Date: 1979 Jul-Aug Impact factor: 3.105

3. Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease.

Authors: V Legrand; M Vandormael; P Collignon; H E Kulbertus
Journal: Am J Cardiol Date: 1983-02 Impact factor: 2.778

4. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.

Authors: K J Hellestrand; A W Nathan; R S Bexton; R A Spurrell; A J Camm
Journal: Am J Cardiol Date: 1983-03-01 Impact factor: 2.778

5. Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens.

Authors: H J Crijns; L M van Wijk; W H van Gilst; J H Kingma; I C van Gelder; K I Lie
Journal: Eur Heart J Date: 1988-06 Impact factor: 29.983

6. Flecainide for supraventricular tachycardia in children.

Authors: V Zeigler; P C Gillette; B Hammill; B A Ross; L Ewing
Journal: Am J Cardiol Date: 1988-08-25 Impact factor: 2.778

7. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.

Authors: B Musto; A D'Onofrio; C Cavallaro; A Musto; R Greco
Journal: Am J Cardiol Date: 1988-08-01 Impact factor: 2.778

New antiarrhythmic drugs. II. Flecainide.

1. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.

2. Electrophysiological effects of a new antiarrhythmic agent, flecainide, on the intact canine heart.

3. Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease.

4. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.

5. Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens.

6. Flecainide for supraventricular tachycardia in children.

7. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.

8. Experience with flecainide for the treatment of cardiac arrhythmias in children.

9. Use of flecainide acetate for refractory junctional tachycardias in children with the Wolff-Parkinson-White syndrome.

10. Electrophysiologic effects of flecainide acetate in patients with sinus nodal dysfunction.

Review 1. Safety issues in the treatment of paediatric supraventricular tachycardias.